三七总皂苷对脑缺血/再灌注损伤保护机制的研究进展

翟晓晨,吴捷

中国药学杂志 ›› 2016, Vol. 51 ›› Issue (1) : 6-9.

PDF(598 KB)
PDF(598 KB)
中国药学杂志 ›› 2016, Vol. 51 ›› Issue (1) : 6-9. DOI: 10.11669/cpj.2016.01.002
综述

三七总皂苷对脑缺血/再灌注损伤保护机制的研究进展

  • 翟晓晨,吴捷*
作者信息 +

Research Progress in Protective Mechanism of Panax Notoginsenosidum on Cerebral Ischemia-Reperfusion Injury

  • ZHAI Xiao-chen,WU Jie*
Author information +
文章历史 +

摘要

三七总皂苷(panax notoginsenosidum, PNS)具有增加脑血流量,改善微循环和抗血小板聚集等作用,在临床上广泛用于脑缺血/再灌注损伤(cerebral ischemia-reperfusion injury,CIRI)的治疗。目前研究认为,三七总皂苷对脑缺血/再灌注损伤的保护机制涉及其对自由基及脂质过氧化物、细胞凋亡、钙通道、神经元损伤、相关信号通路蛋白表达等多方面作用。这些结果为三七总皂苷的合理开发和应用提供了充分的科学依据。笔者对近年来国内外有关文献进行了检索和分析,现对三七总皂苷保护脑缺血/再灌注损伤机制的研究进展予以综述。

Abstract

Panax notoginsenosidum(PNS),which was proved to have the efficacy of increasing cerebral blood flow,improving microcirculation and anti-platelet aggregation, has been widely used for the treatment of cerebral ischemia-reperfusion injury(CIRI). A line of current studies have shown that the protective mechanism of PNS on CIRI is associated with multiple ways, including the roles of PNS on free radicals and lipid peroxides, apoptosis, calcium channels, neuronal damage, and the protein expression of signaling pathways etc. The above protective mechanisms underlying the role of PNS on CIRI provide well-founded scientific evidences for the exploitation and application of PNS. In this paper, the progress in protective mechanism of PNS on CIRI by summarizing and analyzing data collected from literatures published in recent years is reviewed.

关键词

三七总皂苷 / 脑缺血/再灌注损伤 / 保护机制

Key words

panax notoginsenosidum / cerebral ischemia-reperfusion injury / protective mechanism

引用本文

导出引用
翟晓晨,吴捷. 三七总皂苷对脑缺血/再灌注损伤保护机制的研究进展[J]. 中国药学杂志, 2016, 51(1): 6-9 https://doi.org/10.11669/cpj.2016.01.002
ZHAI Xiao-chen,WU Jie. Research Progress in Protective Mechanism of Panax Notoginsenosidum on Cerebral Ischemia-Reperfusion Injury[J]. Chinese Pharmaceutical Journal, 2016, 51(1): 6-9 https://doi.org/10.11669/cpj.2016.01.002
中图分类号: R965   

参考文献

[1] WANG J,LIU C M,LI L,et al. Isolation of four high-purity dammarane saponins fromextract of Panax notoginseng by centrifugal partition chromatography coupled with evaporative light scattering detection in one operation. Phytochem Anal,2011,22(3):263-267.
[2] CHEN X Y. Role of inflammatory factor inbrain damage with cerebral ischemia rat caused by MMP and TIMP-1. J Sun Yat-sen Univ(Med Sci)(中山大学学报医学科学版),2013,34(2):230-234.
[3] TANG Y H,HUANG X P,TAN H,et al. Effect of Panax notoginseng saponins on MMP-9 and TIMP-1 after cerebral ischemia-reperfusion in mice. J Tradit Chin Med Univ Hunan(湖南中医药大学学报),2010,30(5):29-31.
[4] YANG F. Effect of early use PNS on neurological recovery in cerebral hemorrhage patients. Chin J Pract Nerv Dis(中国实用神经疾病杂志),2013,16(18):86-87.
[5] WANG Y,XU D M,WANG W,et al. Advance inapoptosis mechanism on nerve cell after cerebral ischemia-reperfusion and neuroprotective drugs(review). Chin J Rehabil Theory Pract(中国康复理论与实践),2010,16(12):1140-1143.
[6] LIU G,WANG T,WANG T,et al. Effects of apoptosis-related proteins caspase-3, Bax and Bcl-2 on cerebral ischemia rats. Biomed Rep, 2013,1(6):861-867.
[7] JIANG Y J. Effect of Xueshuantong powder(Panax notoginseng saponins) injection on the expression of Bcl-2 protein after ischemia reperfusion. J Emeg Tradit Chin Med(中国中医急症),2013,22(9):1546-1548.
[8] ZHU D L,ZHU P,WANG R J,et al. Effect of total Panax notoginseng saponinsin(PNS) on the expression of Bax in brain after brain damage induced by asphyxia in neonatal SD rats. Maternal Child Health Care China(中国妇幼保健),2013,28(16):2608-2611.
[9] WANG K,LIN B. Inhibitor of apoptosis proteins (IAPs) as regulatory factors ofhepatic apoptosis. Cell Signal,2013,25(10):1970-1980.
[10] TANG Y H,HUANG X P,TAN H,et al. Effect of Panax notoginseng saponins on neuronal apoptosis and mitochondrial apoptosis pathway expression c-Jun N-terminal kinase after cerebral ischemia-reperfusion in Mice. Chin J Exp Tradit Med Form(中国实验方剂学杂志),2010,16(15):129-136.
[11] ZHU J H,WANG D K,DONG K Q,et al. The neural protection of total Panax notoginseng saponins in rats with intracerebral hemorrhage. Chin J Clin Anat(中国临床解剖学杂志),2014,32(4):442-445.
[12] LI H,DENG C Q,CHEN B Y,et al. Total saponins of Panax Notoginseng modulate theexpression of caspases and attenuate apoptosis in rats following focal cerebral ischemiareperfusion. J Ethnophar macol,2009,121(3):412-418.
[13] WANG Q,SUN Z,MAI SU ER MMTZN,et al. The influence on the inhibition of apoptosis of total saponins of Panax notoginseny on cerebral ischemia reperfusion injury in rats. Prog Mod Biomed(现代生物医学进展),2013,13(15):2804-2808.
[14] JIANG W,XIA F,HAN J,et al. Patterns of nogo-A, NgR, and RhoA expression in the brain tissues of rats with focal cerebral infarction. Transl Res,2009,154(1):40-48.
[15] LIU W,LIU L X,SHI X W,et al. Effect of total saponins of Panax notognseng injection on the expression of Nogo-A/Ngr/Rhoa signaling regulation pathway in hippocampus CA1 in rats with middle cerebral artery occlusion. Chin J Integr Med on Cardio/Cerebro-vascular Dis(中西医结合心脑血管病杂志),2014,12(11):1370-1373.
[16] WU J H,ZHANG X Q,ZHU L Q,et al. Effects of Xuesaitong lyophilized powder on expressionof Nogo-A in hippocampus in ratswith focal cerebral ischemia. J Emerg Tradit Chin Med(中国中医急症),2013,22(4):521-523.
[17] LIU L X,ZHU L,ZOU Y,et al. Panax notoginseng saponins promotes stroke recovery by influencing expression of Nogo-A, Ng-Rand p75NGF, in vitro and in vivo. Biol Pharm Bull,2014,37(4):560-568.
[18] LIU X Q,SHENG R,QIN Z H.The neuroprotective mechanism of brain ischemic preconditioning. Acta Pharmacol Sin(中国药理学报),2009,30(8):1071-1080.
[19] LEE E,SIDORYK W M,WANG N,et al. GPR30 Regulates glutamate transporter GLT-1 expression in rat primary astrocytes. J Biol Chem,2012,287(32):26817-26828.
[20] CHEN J W,TAN M Y,CHEN H F,et al. Role of ginsenoside Rb_3 on the excitatory amino acids in rat brain after ischemia reperfusion. Chin Med Mater(中药材),2012,35(8):1301-1304.
[21] ZHANG X,SHI M,BJRS M,et al. Ginsenoside Rd promotes glutamate clearance by upregulating glial glutamate transporter GLT-1 via PI3K/AKT and ERK1/2 pathways. Frontiers Pharmacol,2013,4:152-160.
[22] LU H,ZHENG X C. The progress of cerebral ischemia reperfusion injury and mitochondria. J Trauma Emerg(创伤与急诊电子杂志),2013,1(3):5-9.
[23] LIU W H,LI H,ZHOU X Q,et al. Study on the expression of Smac, XIAP and Caspase-9 in rats with cerebral ischemia/reperfution and the interventional effects of Huoxue Tongluo recipe. Prog Mod Biomed(现代生物医学进展),2009,9(13):2424-2427.
[24] LEE J C,WON M H. Neuroprotection of antioxidant enzymes against transient global cerebral ischemia in gerbils. Adv Anat Embryol Cel,2014,47(3):149-156.
[25] GONG J,SUN F,LI Y,et al. Momordica charantia polysaccharides could protect against cerebral ischemia/reperfusion injury through inhibiting oxidative stress mediated c-Jun Nterminal kinase 3 signaling pathway. Neuropharmacology,2015,91:123-134.
[26] CHEN F,YANG S Q,JIANG P Q,et al. Protective effect of Xuesaitong injections on cerebral ischemic reperfusion injury in rats. Med Innov China(中国医学创新),2014,11(7):15-17.
[27] LONG M,WANG Q,YAN Y X,et al. The influence on the expression of MDA and GSH-XPof total saponins of Panax notoginseny on cerebral ischemia reperfusion injury in rats. Prog Mod Biomed(现代生物医学进展),2013,13(12):2257-2272.
[28] TANG Y H,HUANG X P,TAN H,et al. Effect of Panax notoginseng saponins on extracellular matrix damage and oxidative stress after cerebral ischemia-reperfusion in mice. Chin Arch Tradit Chin Med(中华中医药学刊),2010,28(11):2327-2330.
[29] SHICHINOHE H,ISHIHARA T,TAKAHASHI K,et al. Bone marrow stromal cells rescue ischemic brain by trophic effects and phenotypic change toward neural cells. Neurorehab Neural Re,2015,29(1):80-89.
[30] ZHANG B X,ZHANG J S,DU M M,et al. Mobilizing effect of Panax notoginseng saponins on marrow mesenchymal stem cells in model of cerebral ischemic-reperfusion injury. J Beijing Univ Tradit Chin Med(北京中医药大学学报),2014,37(6):387-392.

基金

国家自然科学基金资助项目(81273501;81470378)
PDF(598 KB)

Accesses

Citation

Detail

段落导航
相关文章

/